State of Wisconsin Investment Board’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-79,680
| Closed | -$3.21M | – | 2538 |
|
|
2026
Q1 | $3.21M | Buy |
79,680
+12,764
| +19% | +$275K | 0.01% | 1170 |
|
|
2025
Q4 | $1.68M | Sell |
66,916
-18,845
| -22% | -$442K | ﹤0.01% | 1480 |
|
|
2025
Q3 | $1.94M | Sell |
85,761
-8,643
| -9% | -$202K | ﹤0.01% | 1376 |
|
|
2025
Q2 | $1.63M | Buy |
94,404
+9,789
| +12% | +$181K | ﹤0.01% | 1385 |
|
|
2025
Q1 | $1.85M | Buy |
84,615
+4,233
| +5% | +$117K | ﹤0.01% | 1278 |
|
|
2024
Q4 | $2.56M | Sell |
80,382
-657
| -0.8% | -$19.8K | 0.01% | 1192 |
|
|
2024
Q3 | $2.34M | Buy |
81,039
+3,690
| +5% | +$137K | 0.01% | 1251 |
|
|
2024
Q2 | $2.97M | Buy |
77,349
+25,674
| +50% | +$1.16M | 0.01% | 1135 |
|
|
2024
Q1 | $3.04M | Sell |
51,675
-16,130
| -24% | -$1.03M | 0.01% | 1126 |
|
|
2023
Q4 | $4.06M | Sell |
67,805
-14,967
| -18% | -$759K | 0.01% | 1047 |
|
|
2023
Q3 | $3.15M | Buy |
82,772
+5,952
| +8% | +$261K | 0.01% | 1113 |
|
|
2023
Q2 | $7M | Sell |
76,820
-4,764
| -6% | -$411K | 0.02% | 784 |
|
|
2023
Q1 | $5.38M | Sell |
81,584
-6,574
| -7% | -$379K | 0.02% | 912 |
|
|
2022
Q4 | $4.56M | Buy |
88,158
+6,968
| +9% | +$370K | 0.01% | 988 |
|
|
2022
Q3 | $5.54M | Sell |
81,190
-1,926
| -2% | -$114K | 0.02% | 883 |
|
|
2022
Q2 | $3.76M | Sell |
83,116
-12,584
| -13% | -$574K | 0.01% | 1141 |
|
|
2022
Q1 | $4.86M | Hold |
95,700
| – | – | 0.01% | 1170 |
|
|
2021
Q4 | $4.53M | Buy |
95,700
+5,700
| +6% | +$224K | 0.01% | 1073 |
|
|
2021
Q3 | $2.97M | Buy |
90,000
+9,100
| +11% | +$511K | 0.01% | 1192 |
|
|
2021
Q2 | $5.11M | Hold |
80,900
| – | – | 0.01% | 1041 |
|
|
2021
Q1 | $3.47M | Sell |
80,900
-4,700
| -5% | -$222K | 0.01% | 1119 |
|
|
2020
Q4 | $4.9M | Sell |
85,600
-10,700
| -11% | -$453K | 0.01% | 988 |
|
|
2020
Q3 | $2.9M | Hold |
96,300
| – | – | 0.01% | 1089 |
|
|
2020
Q2 | $3.15M | Sell |
96,300
-98,005
| -50% | -$3.15M | 0.01% | 1020 |
|
|
2020
Q1 | $5.21M | Buy |
194,305
+122,105
| +169% | +$4.34M | 0.02% | 768 |
|
|
2019
Q4 | $2.21M | Hold |
72,200
| – | – | 0.01% | 1126 |
|
|
2019
Q3 | $1.74M | Buy |
72,200
+20,200
| +39% | +$556K | ﹤0.01% | 1043 |
|
|
2019
Q2 | $1.32M | Buy |
52,000
+1,100
| +2% | +$22.4K | ﹤0.01% | 1077 |
|
|
2019
Q1 | $993K | Buy |
50,900
+13,800
| +37% | +$217K | ﹤0.01% | 1160 |
|
|
2018
Q4 | $489K | Buy |
37,100
+300
| +0.8% | +$4.6K | ﹤0.01% | 1320 |
|
|
2018
Q3 | $654K | Hold |
36,800
| – | – | ﹤0.01% | 1336 |
|
|
2018
Q2 | $810K | Buy |
+36,800
| New | +$845K | ﹤0.01% | 1241 |
|
Other funds holding APLS
State of Wisconsin Investment Board's APLS Position: Q2 2026 in Review
State of Wisconsin Investment Board sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 79,680 shares — an estimated $3.21M sold.
State of Wisconsin Investment Board first reported a position in APLS in Q2 2018 and held it in 32 quarters. The position peaked at $7M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- State of Wisconsin Investment Board reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- State of Wisconsin Investment Board sold 79,680 Apellis Pharmaceuticals shares in Q2 2026, an estimated $3.21M.
- State of Wisconsin Investment Board first reported a position in Apellis Pharmaceuticals in Q2 2018 and held it in 32 quarters.
- State of Wisconsin Investment Board's Apellis Pharmaceuticals position peaked at $7M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.